Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | HTR1B | P28222 | 1/20 | 0.32 |
| ▸ | DNM2 | P50570 | 3/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 7/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19005907 | 0.92 | ACHE (0.36) | ACHEESR1LMNASMN1; SMN2 | |
| SCHEMBL18267832 | 0.80 | RAB9A (0.39) | HTR1DHTR1BSMN1; SMN2 | |
| SCHEMBL18544469 | 0.80 | ACHE (0.33) | ACHEDNM2S1PR2LMNASMN1; SMN2 | |
| SCHEMBL18267838 | 0.78 | PGR (0.44) | HTR1DHTR1BPGRSMN1; SMN2 | |
| SCHEMBL18812509 | 0.77 | ACHE (0.33) | ACHEDNM2MAOB | |
| SCHEMBL13502625 | 0.77 | L3MBTL1 (0.41) | SOAT1 | |
| SCHEMBL18386512 | 0.76 | MMP3 (0.39) | SOAT1DNM2S1PR2LMNASMN1; SMN2 | |
| SCHEMBL22878675 | 0.76 | MMP3 (0.39) | SOAT1DNM2S1PR2LMNASMN1; SMN2 | |
| SCHEMBL19107921 | 0.75 | ACHE (0.32) | ACHE | |
| SCHEMBL25450824 | 0.75 | PGR (0.46) | HTR1DHTR1BPGRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10008671-B2 | Organic thin-film transistor and method for manufacturing same | FUJIFILM CORPORATION (JP) | 2018-06-26 | — | — | US | disclosed |
| US-20170309836-A1 | ORGANIC SEMICONDUCTOR LIQUID COMPOSITION, ORGANIC SEMICONDUCTOR ELEMENT, AND METHOD FOR PREPARING ORGANIC SEMICONDUCTOR ELEMENT | FUJIFILM CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10008671-B2 | Organic thin-film transistor and method for manufacturing same | TET1, FTO, TET2 | ACHE 1200/4885SOAT1 209/4885HTR1D 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.